植込み型除細動器（ICD）のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2023年版）

当レポートでは、植込み型除細動器（ICD）のパイプライン製品について調査分析し、各開発段階における製品の比較分析や、進行中の臨床試験についての情報を含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 植込み型除細動器（ICD） - パイプライン製品：開発段階別
• 植込み型除細動器（ICD） - パイプライン製品：セグメント別
• 植込み型除細動器（ICD） - パイプライン製品：地域別
• 植込み型除細動器（ICD） - パイプライン製品：規制経路別
• 植込み型除細動器（ICD） - パイプライン製品：推定承認日別
• 植込み型除細動器（ICD） - 進行中の臨床試験

第4章 植込み型除細動器（ICD） - 開発中のパイプライン製品：企業別

• 植込み型除細動器（ICD）企業 - パイプライン製品：開発段階別
• 植込み型除細動器（ICD） - パイプライン製品：開発段階別

第5章 植込み型除細動器（ICD）の企業と製品の概要

• Advanced BioInformatics GmbH：企業の概要
  • Advanced BioInformatics GmbH：パイプライン製品と進行中の臨床試験の概要
• AIS Inc.：企業の概要
  • AIS Inc.：パイプライン製品と進行中の臨床試験の概要
• Arrhythmia Dynamics LLC：企業の概要
  • Arrhythmia Dynamics LLC：パイプライン製品と進行中の臨床試験の概要
• AtaCor Medical Inc：企業の概要
  • AtaCor Medical Inc：パイプライン製品と進行中の臨床試験の概要
• Boston Scientific Corp：企業の概要
  • Boston Scientific Corp：パイプライン製品と進行中の臨床試験の概要
• CardiaLen, Inc.：企業の概要
  • CardiaLen, Inc.：パイプライン製品と進行中の臨床試験の概要
• Coridea, LLC：企業の概要
  • Coridea, LLC：パイプライン製品と進行中の臨床試験の概要
• Impulse Dynamics Germany GmbH：企業の概要
  • Impulse Dynamics Germany GmbH：パイプライン製品と進行中の臨床試験の概要
• InnerPulse Inc（休止中）：企業の概要
  • InnerPulse Inc（休止中）：パイプライン製品と進行中の臨床試験の概要
• Johns Hopkins University：企業の概要
  • Johns Hopkins University：パイプライン製品と進行中の臨床試験の概要
• Kenergy Inc.：企業の概要
  • Kenergy Inc.：パイプライン製品と進行中の臨床試験の概要
• Massachusetts General Hospital：企業の概要
  • Massachusetts General Hospital：パイプライン製品と進行中の臨床試験の概要
• Max Planck Institute for Dynamics and Self-Organization：企業の概要
  • Max Planck Institute for Dynamics and Self-Organization：パイプライン製品と進行中の臨床試験の概要
• Medicool Technologies Inc：企業の概要
  • Medicool Technologies Inc：パイプライン製品と進行中の臨床試験の概要
• Medtronic Inc：企業の概要
  • Medtronic Inc：パイプライン製品と進行中の臨床試験の概要
• Medtronic Plc：企業の概要
  • Medtronic Plc：パイプライン製品と進行中の臨床試験の概要
• MicroPort CRM SA：企業の概要
  • MicroPort CRM SA：パイプライン製品と進行中の臨床試験の概要
• MicroPort Scientific Corp：企業の概要
  • MicroPort Scientific Corp：パイプライン製品と進行中の臨床試験の概要
• Smartwave Medical Ltd（休止中）：企業の概要
  • Smartwave Medical Ltd（休止中）：パイプライン製品と進行中の臨床試験の概要
• University of Chicago：企業の概要
  • University of Chicago：パイプライン製品と進行中の臨床試験の概要

第6章 植込み型除細動器（ICD） - 最近の開発

第7章 付録

Abstract

GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart's rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart's natural rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Implantable Cardioverter Defibrillators (ICD) Overview

3 Products under Development

• 3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
• 3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
• 3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
• 3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
• 3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
• 3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials

4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies

• 4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
• 4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview

• 5.1 Advanced BioInformatics GmbH Company Overview
  • 5.1.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 AIS Inc. Company Overview
  • 5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Arrhythmia Dynamics LLC Company Overview
  • 5.3.1 Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 AtaCor Medical Inc Company Overview
  • 5.4.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Boston Scientific Corp Company Overview
  • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 CardiaLen, Inc. Company Overview
  • 5.6.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Coridea, LLC Company Overview
  • 5.7.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Impulse Dynamics Germany GmbH Company Overview
  • 5.8.1 Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 InnerPulse Inc (Inactive) Company Overview
  • 5.9.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Johns Hopkins University Company Overview
  • 5.10.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Kenergy Inc. Company Overview
  • 5.11.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Massachusetts General Hospital Company Overview
  • 5.12.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Max Planck Institute for Dynamics and Self-Organization Company Overview
  • 5.13.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Medicool Technologies Inc Company Overview
  • 5.14.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Medtronic Inc Company Overview
  • 5.15.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Medtronic Plc Company Overview
  • 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 MicroPort CRM SA Company Overview
  • 5.17.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 MicroPort Scientific Corp Company Overview
  • 5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Smartwave Medical Ltd (Inactive) Company Overview
  • 5.19.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 University of Chicago Company Overview
  • 5.20.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview

6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments

• 6.1 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
• 6.2 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
• 6.3 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023
• 6.4 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
• 6.5 Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
• 6.6 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
• 6.7 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability
• 6.8 Nov 23, 2022: Medtronic Reports Quarterly Earnings
• 6.9 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
• 6.10 Nov 17, 2022: Mindray North America unveils new true to life vital signs monitor
• 6.11 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
• 6.12 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023
• 6.13 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
• 6.14 Oct 31, 2022: Fukuda Denshi Financial Results for the Second Quarter of the Fiscal Year Ending March 2023
• 6.15 Oct 31, 2022: Fukuda Denshi Notice of the Revision Forecast of the Financial Results, Distribution of Surplus and Year-end Dividend Forecast, Stock Split
• 6.16 Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges
• 6.17 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results
• 6.18 Oct 12, 2022: Philips provides update on its financial performance in Q3 2022
• 6.19 Sep 07, 2022: Medtronic to appear at September investor conferences
• 6.20 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
• 6.21 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
• 6.22 Aug 18, 2022: Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer
• 6.23 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
• 6.24 Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
• 6.25 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders
• 6.26 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
• 6.27 May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes
• 6.28 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
• 6.29 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
• 6.30 May 13, 2022: Nihon Kohden Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
• 6.31 May 13, 2022: Nihon Kohden announces FY2021 consolidated financial results
• 6.32 May 04, 2022: Conmed Announces First Quarter 2022 Financial Results
• 6.33 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
• 6.34 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer